Keyphrases
Betulinic Acid
100%
Triple-negative Breast Cancer
100%
Andrographolide
100%
Apoptosis
40%
Breast Cancer
40%
Angiogenesis
40%
Triple-negative Breast Cancer Cells
40%
Phytochemicals
20%
Cell Cycle Arrest
20%
Molecular Mechanism
20%
Inflammatory Response
20%
Plant Extracts
20%
Inflammation
20%
Progesterone Receptor
20%
Estrogen Receptor
20%
Conventional Chemotherapy
20%
Immune Response
20%
Plant Use
20%
Treatment Strategy
20%
Breast Cancer Subtypes
20%
Poor Prognosis
20%
Breast Cancer Cell Lines
20%
MDA-MB-231
20%
Acquired Drug Resistance
20%
Antitumor Compounds
20%
Toxic Side Effects
20%
Chemotherapeutic Approaches
20%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Epidermal Growth Factor Receptor
20%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Angiogenesis
100%
Cell Cycle Arrest
50%
Plant Extract
50%
Immune Response
50%
Drug Resistance
50%
Epidermal Growth Factor Receptor
50%
Progesterone Receptor
50%
Estrogen Receptor
50%
Phytochemical
50%
Cell Cycle Checkpoint
50%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Betulic Acid
100%
Andrographolide
100%
Breast Cancer
42%
Programmed Cell Death
28%
Angiogenesis
28%
Neoplasm
14%
Phytochemical
14%
Serositis
14%
Cancer Cell
14%
Cell Cycle Arrest
14%
Chemotherapy
14%
Immune Response
14%
Side Effect
14%
Plant Extract
14%
Breast Cancer Cell Line
14%
Malignant Neoplasm
14%
Gamma Urogastrone
14%
Epidermal Growth Factor Receptor 2
14%
Drug Resistance
14%
Progesterone Receptor
14%
Estrogen Receptor
14%
Cell Cycle Checkpoint
14%
Pharmacology, Toxicology and Pharmaceutical Science
Betulinic Acid
100%
Andrographolide
100%
Triple Negative Breast Cancer
100%
Breast Cancer
42%
Inflammation
28%
Chemotherapy
14%
Plant Extract
14%
Malignant Neoplasm
14%
Phytochemical
14%
Side Effect
14%
Estrogen Receptor
14%
Epidermal Growth Factor Receptor 2
14%
Gamma Urogastrone
14%
Drug Resistance
14%
Neoplasm
14%
Progesterone Receptor
14%